Cavanaugh, Juleen - The Australian National University

个人简介

Dr Juleen Cavanaugh is a Visiting Fellow at the Research School of Biology. She is based at the ANU Medical School, and the Canberra Hospital. Juleen is retired, and no longer taking students.

研究领域

I am interested in both simple and complex inherited disorders from diseases such as haemochromatosis and the aminoacidurias to more complex dieases such as thyroid disease, multiple sclerosis and inflammatory bowel disease. A large project called the "Aussie Normals" in collaboration with staff at The Canberra Hospital is investigating genotype and phenotype in healthy individuals in the Canberra Region.

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Fowler, EV; Doecke, J; Simms, LA; et al ATG16L1 T300A Shows Strong Associations With Disease Subgroups in a Large Australian IBD Population: Further Support for Significant Disease Heterogeneity., American Journal of Gastroenterology 103:10, pp 2519-2526, Schmuck, E; Cappello, J; Coggan, M; et al.Deletion of Glu155 causes a deficiency of glutathione transferase Omega 1-1 but does not alter sensitivity to arsenic trioxide and other cytotoxic drugs, International Journal of Biochemistry & Cell BIOLOGY 40:11, pp 2553-2559, Hugot, JP; Zaccaria, I; Cavanaugh, J; et al, Prevalence of CARD15/NOD2 mutations in Caucasian healthy people, American Journal of Gastroenterology 102:6, pp1259-1267 Hume, GE; Fowler, EV; Lincoln, D; et al, Angiotensinogen and transforming growth factor beta 1: novel genes in the pathogenesis of Crohn's disease, Journal of Medical Genetics 43:10 Published: OCT 2006, IL1RN genotype as a risk factor for joint pain in hereditary haemochromatosis?, Walker, EJ; Riddell, J; Rodgers, HJ; et al., Annals of the Rheumatic Diseases 65, pp 271-272 Cavanaugh, J, NOD2: Ethnic and geographic differences, World Journal of Gastroenterology 12:23, pp 3673-3677 Screening for hemochromatosis in asymptomatic subjects with or without a family history, Powell, LW; Dixon, JL; Ramm, GA; et al., Archives of Internal Medicine 166:3, pp 294-301 Walsh, A; Dixon, JL; Ramm, GA; et al. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis, Clinical Gastroenterology and Hepatology 4:11, pp 1403-1410 Schmuck, EM; Board, PG; Whitbread, AK; et al. Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: implications for arsenic metabolism and the age-at-onset of Alzheimer's and Parkinson's diseases, Pharmacogenetics and Genomics 15:7, pp 493- Peters, KE; O'Callaghan, NJ; Cavanaugh, Lack of association of the CD14 promoter polymorphism-159C/T with Caucasian inflammatory bowel disease, JA Scandinavian Journal of Gastroenterology 40:2, pp 194-197.